Blu Biotech

Cancer Screening in minutes, without a lab, using just a single exhaled breath.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location New York, NY, USA
  • Currency USD
  • Founded November 2019
  • Employees 3
  • Incorporation Type C-corp
  • Website blubiotech.com

Company Summary

Early and late stage Colorectal and Lung Cancer screening using breath performed by a micro gas chromatography system. The screening requires a breath collection, the device detects Cancer in 25 minutes without a lab or special training. Technology developed by the University of Michigan, patented, inventor is a share holder. Exclusive commercialization rights to the technology. Lab results suggest better accuracy than available products.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free